1. Home
  2. NBTX vs ASM Comparison

NBTX vs ASM Comparison

Compare NBTX & ASM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • ASM
  • Stock Information
  • Founded
  • NBTX 2003
  • ASM 1968
  • Country
  • NBTX France
  • ASM Canada
  • Employees
  • NBTX N/A
  • ASM N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • ASM Metal Mining
  • Sector
  • NBTX Health Care
  • ASM Basic Materials
  • Exchange
  • NBTX Nasdaq
  • ASM Nasdaq
  • Market Cap
  • NBTX 868.8M
  • ASM 798.8M
  • IPO Year
  • NBTX 2020
  • ASM N/A
  • Fundamental
  • Price
  • NBTX $27.75
  • ASM $6.37
  • Analyst Decision
  • NBTX Strong Buy
  • ASM Strong Buy
  • Analyst Count
  • NBTX 1
  • ASM 3
  • Target Price
  • NBTX $8.00
  • ASM $4.40
  • AVG Volume (30 Days)
  • NBTX 162.1K
  • ASM 6.1M
  • Earning Date
  • NBTX 09-30-2025
  • ASM 11-06-2025
  • Dividend Yield
  • NBTX N/A
  • ASM N/A
  • EPS Growth
  • NBTX N/A
  • ASM 1940.36
  • EPS
  • NBTX N/A
  • ASM 0.11
  • Revenue
  • NBTX $11,930,711.00
  • ASM $79,639,000.00
  • Revenue This Year
  • NBTX N/A
  • ASM $35.34
  • Revenue Next Year
  • NBTX $114.97
  • ASM $40.41
  • P/E Ratio
  • NBTX N/A
  • ASM $51.19
  • Revenue Growth
  • NBTX N/A
  • ASM 53.08
  • 52 Week Low
  • NBTX $2.76
  • ASM $0.85
  • 52 Week High
  • NBTX $30.35
  • ASM $5.64
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 66.10
  • ASM 75.91
  • Support Level
  • NBTX $23.31
  • ASM $5.00
  • Resistance Level
  • NBTX $29.72
  • ASM $5.64
  • Average True Range (ATR)
  • NBTX 2.12
  • ASM 0.40
  • MACD
  • NBTX 0.66
  • ASM 0.05
  • Stochastic Oscillator
  • NBTX 80.80
  • ASM 98.46

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About ASM Avino Silver & Gold Mines Ltd. (Canada)

Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.

Share on Social Networks: